Ted Gooley

29.7k total citations · 4 hit papers
322 papers, 18.3k citations indexed

About

Ted Gooley is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Ted Gooley has authored 322 papers receiving a total of 18.3k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Hematology, 91 papers in Oncology and 79 papers in Immunology. Recurrent topics in Ted Gooley's work include Hematopoietic Stem Cell Transplantation (157 papers), Acute Myeloid Leukemia Research (60 papers) and Acute Lymphoblastic Leukemia research (45 papers). Ted Gooley is often cited by papers focused on Hematopoietic Stem Cell Transplantation (157 papers), Acute Myeloid Leukemia Research (60 papers) and Acute Lymphoblastic Leukemia research (45 papers). Ted Gooley collaborates with scholars based in United States, South Africa and Germany. Ted Gooley's co-authors include Barry E. Storer, Wendy M. Leisenring, John Crowley, Rainer Storb, Frederick R. Appelbaum, Michael Boeckh, Paul J. Martin, Brenda M. Sandmaier, W. Garrett Nichols and Lawrence Corey and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ted Gooley

312 papers receiving 17.9k citations

Hit Papers

Estimation of failure pro... 1995 2026 2005 2015 1999 2010 1995 2016 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
    1999 2.1k citations Ted Gooley, Barry E. Storer et al. profile →
  2. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
    2010 1.0k citations Ted Gooley, Mohamed L. Sorror et al. profile →
  3. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
    1995 529 citations Scott D. Rowley, Rainer Storb et al. profile →
  4. Cord-Blood Transplantation in Patients with Minimal Residual Disease
    2016 284 citations Filippo Milano, Ted Gooley et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ted Gooley 10.3k 4.9k 4.7k 3.0k 2.6k 322 18.3k
Donna Przepiorka 12.0k 1.2× 5.5k 1.1× 5.6k 1.2× 2.6k 0.9× 1.9k 0.7× 197 18.2k
Brenda M. Sandmaier 16.1k 1.6× 5.4k 1.1× 5.1k 1.1× 4.8k 1.6× 2.6k 1.0× 421 21.8k
Keith M. Sullivan 11.0k 1.1× 3.9k 0.8× 4.6k 1.0× 2.7k 0.9× 1.9k 0.7× 241 16.5k
Jeff Szer 8.4k 0.8× 3.5k 0.7× 4.8k 1.0× 1.9k 0.7× 1.8k 0.7× 385 15.3k
Corey Cutler 13.1k 1.3× 4.0k 0.8× 6.8k 1.4× 3.1k 1.0× 1.2k 0.5× 449 18.2k
Mary E.D. Flowers 14.2k 1.4× 4.8k 1.0× 5.4k 1.1× 3.9k 1.3× 2.9k 1.1× 339 20.0k
Jakob Passweg 13.3k 1.3× 6.1k 1.3× 4.7k 1.0× 2.7k 0.9× 1.8k 0.7× 497 21.0k
Didier Blaise 12.1k 1.2× 5.0k 1.0× 5.1k 1.1× 3.7k 1.3× 1.0k 0.4× 652 16.5k
Vincent T. Ho 10.4k 1.0× 3.4k 0.7× 5.8k 1.2× 2.3k 0.8× 1.2k 0.5× 323 14.9k
Aloïs Gratwohl 17.1k 1.7× 4.7k 1.0× 5.7k 1.2× 4.4k 1.5× 2.2k 0.9× 515 23.8k

Countries citing papers authored by Ted Gooley

Since Specialization
Citations

This map shows the geographic impact of Ted Gooley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Gooley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Gooley more than expected).

Fields of papers citing papers by Ted Gooley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted Gooley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Gooley. The network helps show where Ted Gooley may publish in the future.

Co-authorship network of co-authors of Ted Gooley

This figure shows the co-authorship network connecting the top 25 collaborators of Ted Gooley. A scholar is included among the top collaborators of Ted Gooley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Gooley. Ted Gooley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ebadi, Maryam, Samuel S. Minot, Ted Gooley, et al.. (2025). Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation. Gut Microbes. 17(1). 2551882–2551882.
2.
Ebadi, Maryam, Daniel Podlesny, Samuel S. Minot, et al.. (2025). Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect. Nature Communications. 16(1). 1034–1034. 10 indexed citations
3.
Pidala, Joseph A., Ted Gooley, Leo Luznik, & Bruce R. Blazar. (2024). Chronic graft-versus-host disease: unresolved complication or ancient history?. Blood. 144(13). 1363–1373. 12 indexed citations
4.
Lee, Stephanie J., Corey Cutler, Ted Gooley, et al.. (2023). Dental evaluation and clearance prior to allogeneic hematopoietic cell transplantation. Oral Diseases. 30(4). 2635–2644. 2 indexed citations
5.
Connelly‐Smith, Laura, Ted Gooley, Marco Mielcarek, et al.. (2023). Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. Transplantation and Cellular Therapy. 29(11). 700.e1–700.e8. 4 indexed citations
6.
Orozco, Johnnie J., Ted Gooley, D. Scott Wilbur, et al.. (2023). Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors. Clinical Cancer Research. 30(2). 274–282. 2 indexed citations
7.
Ullrich, Christina, Kelsey K. Baker, Paul A. Carpenter, et al.. (2022). Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies. Transplantation and Cellular Therapy. 29(3). 200.e1–200.e8. 8 indexed citations
8.
Morishima, Yasuo, Satoko Morishima, Yoshihisa Kodera, et al.. (2022). Race and Survival in Unrelated Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 28(7). 357.e1–357.e6. 9 indexed citations
9.
10.
Yeh, Albert C., Paul V. O’Donnell, Gary Schoch, et al.. (2021). Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin. Bone Marrow Transplantation. 57(2). 198–206. 4 indexed citations
11.
Cassaday, Ryan D., Oliver W. Press, John M. Pagel, et al.. (2019). Phase I Study of a CD45-Targeted Antibody–Radionuclide Conjugate for High-Risk Lymphoma. Clinical Cancer Research. 25(23). 6932–6938. 16 indexed citations
12.
Luft, Thomas, Axel Benner, Tobias Terzer, et al.. (2019). EASIX and mortality after allogeneic stem cell transplantation. Bone Marrow Transplantation. 55(3). 553–561. 89 indexed citations
13.
14.
Cho, Eunpi, Philip A. Stevenson, Ted Gooley, et al.. (2015). The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most?. Breast Cancer Research and Treatment. 149(3). 743–749. 24 indexed citations
15.
Lord, James D., Robert C. Hackman, Ted Gooley, et al.. (2010). Blood and Gastric FOXP3+ T Cells Are Not Decreased in Human Gastric Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 17(4). 486–496. 20 indexed citations
16.
Eissa, Hesham, Ted Gooley, Mohamed L. Sorror, et al.. (2010). Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities. Biology of Blood and Marrow Transplantation. 17(6). 908–915. 81 indexed citations
17.
Hockenbery, David M., Scott Cruickshank, Timothy C. Rodell, et al.. (2007). A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood. 109(10). 4557–4563. 79 indexed citations
18.
Baron, F, Rainer Storb, Ted Gooley, et al.. (2005). Assessing donor chimerism level among CD3 T, CD4 T, CD8 T, and NK cells predicts subsequent graft rejection, GVHD, and relapse after allogeneic HCT with nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation. 11(2). 11–11. 7 indexed citations
19.
Schiffman, K, et al.. (2000). Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization.. PubMed. 6(4). 1347–50. 92 indexed citations
20.
Demirer, Taner, Ted Gooley, CD Buckner, et al.. (1995). Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.. PubMed. 15(6). 907–13. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna Przepiorka Breakdown of academic impact, for papers by Brenda M. Sandmaier Breakdown of academic impact, for papers by Keith M. Sullivan Breakdown of academic impact, for papers by Jeff Szer Breakdown of academic impact, for papers by Corey Cutler Breakdown of academic impact, for papers by Mary E.D. Flowers Breakdown of academic impact, for papers by Jakob Passweg Breakdown of academic impact, for papers by Didier Blaise Breakdown of academic impact, for papers by Vincent T. Ho Breakdown of academic impact, for papers by Aloïs Gratwohl
Rankless by CCL
2026